Merus N.v. buy BiotechBee
Start price
24.06.23
/
70%
€23.20
Target price
30.04.26
€40.00
Performance (%)
76.72%
End price
14.12.24
€41.00
Summary
This prediction ended on 14.12.24 with a price of €41.00. With a performance of 76.72% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merus N.v. | - | - | - | - |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % | 53,46 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % | 72,28 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % | 63,08 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % | 60,40 % |
According to BiotechBee what are the pros and cons of Merus N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year